Proteases are candidate biomarkers and therapeutic targets for many diseases. Sensitive and robust techniques are needed to quantify proteolytic activities within the complex biological milieu. We hypothesized that a combinatorial protease substrate library could be used effectively to identify similarities and differences between serum and bronchoalveolar lavage fluid (BALF), two body fluids that are clinically important for developing targeted therapies and diagnostics. We used a concise library of fluorogenic probes to map the protease substrate specificities of serum and BALF from guinea pigs. Differences in the proteolytic fingerprints of the two fluids were striking: serum proteases cleaved substrates containing cationic residues and proline, whereas BALF proteases cleaved substrates containing aliphatic and aromatic residues. Notably, cleavage of proline-containing substrates dominated all other protease activities in both human and guinea pig serum. This substrate profiling approach provides a foundation for quantitative comparisons of protease specificities between complex biological samples.
Proteases have garnered interest as therapeutic targets for a diverse array of human diseases, and protease inhibitors are approved for treatment of hypertension (angiotensin converting enzyme), HIV infection (HIV protease), thrombosis (thrombin), and other conditions (1) . Inhibitors are also in development for validated protease targets in conditions such as type 2 diabetes and osteoporosis, as well as many viral, parasitic, and bacterial infections (2) . In addition, proteases are promising biomarkers for many cancers, respiratory diseases, and neurological disorders (3) .
A key challenge in identification and characterization of disease-relevant proteases is the measurement of enzymatic activity in the milieu of serum and other biological fluids, in which a multitude of proteases and other hydrolases act in concert. Mass spectrometry (MS)-based proteomics and activity-based protein profiling are two powerful techniques capable of detecting proteases and their cleavage products within complex mixtures (4, 5) . MS-based protease profiling techniques have been developed that detect cleavage of synthetic affinitylabeled substrates in serum (6) . In the case of activity-based protein profiling, active site-directed probes are used to selectively enrich a particular enzyme class or family, such as metalloproteases (7) .
As a complement to these methods, an assessment of the global proteolytic specificity "fingerprint" of a complex sample could reveal two important pieces of information not accessible by techniques that only characterize abundance or that focus on only a few selected proteases. First, broad quantitative comparisons across proteolytic specificities can be made. Second, differences can be observed that would have been missed in biased experiments focused on specific proteases.
One method for measuring protease enzyme kinetics and determining substrate specificity involves the use of substratederived peptide probes that remain optically silent in the uncleaved state but fluoresce upon enzymatic cleavage (8) . By assaying proteases with diverse combinatorial probe libraries, substrate specificity can be precisely defined. These probe libraries have been used with great success to determine the properties of purified recombinant proteases representing each of the major protease classes (9,10). However, this approach has not been used to profile the proteolytic activities of biological fluids such as serum. We hypothesized that a combinatorial protease substrate library could be used effectively to identify similarities and differences between serum and bronchoalveolar lavage fluid (BALF), two body fluids that are clinically important for developing targeted therapies and diagnostics.
Materials and methods
We used a concise library of 3375 internally quenched fluorogenic probes (IQFPs) to map the endoprotease specificities of serum and BALF from guinea pigs. Probes in the library contain the sequence MCA-Gly-GlyGly-Xaa-Yaa-Zaa-Gly-Gly-DPA-Lys-Lys, where MCA corresponds to 7-methoxycoumarin-4-acetic acid (fluorophore) and DPA corresponds to N β -(2,4-dinitrophenyl)-L-2,3-diaminopropionic acid (quencher) ( Figure 1A ). Two C-terminal lysines are included to improve aqueous solubility of hydrophobic sequences. Xaa, Yaa, and Zaa correspond to variable residues comprised of equimolar mixtures of similar amino acids: Ala/Val, Asp/Glu, Phe/Tyr, Ile/Leu, Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases Lys/Arg, Asn/Gln, Ser/Thr, or Pro. Amino acids excluded from the library are either chemically incompatible (Cys, Met), interfere with fluorescence (Trp), or are rarely found in protease cleavage sites (His). This library has been previously validated through substrate specificity profiling of purified recombinant endoproteases representing each of the major protease classes, including trypsin, pepsin, metalloproteinase-12 (MMP-12), and calpain-1 (10) .
Each of the 512 wells in the library contains an equimolar mixture of one of the seven amino acid pairs (or proline) at each of three different variable positions. Thus, each well of the library contains an equimolar mixture of eight individual peptides (unless one or more variable positions contains Pro, in which case the well contains fewer sequences). When arrayed in six 96-well microplates, the IQFPs occupy all 96 wells of plates 1-5 except wells G12 and H12. In plate 6, IQFPs occupy columns 1-5 and wells A6 and B6, thus columns 7-12 of the lower plate appear black in the heatmaps shown in Figures 1  and 2 . Library synthesis and quality control procedures are described in detail elsewhere (10) . The IQFP library was obtained from Mimotopes (Clayton, Victoria, Australia). Unless otherwise indicated, all other chemicals and reagents were from SigmaAldrich (St. Louis, MO, USA) or VWR Scientific (Radnor, PA, USA).
Contents of library wells (5 nmol total peptide/well) were dissolved in 5 µL 50% acetonitrile (ACN) in ultrapure water, further diluted in 45 µL sterile-filtered serine protease buffer (50 mM HEPES, 100 mM NaCl, 10 mM CaCl 2 , pH 8.0), and subdivided into two aliquots of 25 µL each. Assays were conducted in buffer conditions commonly used for characterization of serine proteases, which are abundant in serum and BALF (11, 12) . For each assay, one aliquot of this solution was transferred to low volume 96-well black microplates (Molecular Devices, Sunnyvale, CA, USA). At t = 0 min, the appropriate biological sample (25 µL/well) was added to the microplates containing the IQFP library.
Biological samples were thawed on ice immediately prior to the assay. Complement preserved normal human serum was obtained from Innovative Research (Novi, MI, USA), stored at -80°C until use, and used as supplied. Guinea pig BALF and serum were generously provided by Tom Patterson at the University of Texas Health Science Center at San Antonio. These samples were collected from immunosuppressed male Hartley guinea pigs (0.5 kg; Charles River Laboratories, Wilmington, MA, USA) (13) . The proteolytic activities of fluids derived from immunosuppressed animals are of interest because immunodeficiency is a key risk factor for many infections (14, 15) and immunosuppressed animals are important models of these diseases (16) . The immunosuppression regimen was administered on days 0 and 5, and the samples were collected on day 9. Samples were stored at -80°C, shipped overnight on dry ice, immediately placed in -80°C, and stored at -80°C until use. For guinea pig BALF and serum, aliquots from multiple animals were pooled immediately prior to the assay (4-5 animals/ microplate). Human serum and pooled guinea pig serum samples were diluted 1:1 in assay buffer prior to use. Pooled guinea pig BALF samples were used undiluted. Protein content of pooled guinea pig BALF and serum preparations was 0.35-0.38 mg/mL and 50.8-51.9 mg/mL, respectively, as determined by the bicinchoninic acid (BCA; Pierce, Rockford, IL,USA) and Bio-Rad Laboratories (Hercules, CA, USA) protein assays.
Time-resolved fluorescence data were obtained on an Analyst HT instrument (Molecular Devices) using excitation and emission filters of 320 and 420 nm, respectively, with readings taken every 3-5 min for 5 h (human serum) or 6 h (guinea pig serum and BALF) at room temperature. No fluorescence enhancement was observed in wells containing IQFPs only or in wells containing control medium (data not shown). Raw fluorescence intensity (FI) data were exported to Microsoft Excel, and end point fluorescence intensity fold change values were calculated as F final /F initial where t inital is 0 h and t final is 5 h (human serum) or 6 h (guinea pig serum and BALF). Wells were considered positive if greater than a 2-fold increase in FI was observed. Heatmaps were generated from fold change data in which each square corresponds to a single assay well of stacked 96-well microplates (Heatmap Builder, Ashley Lab, Stanford University) (17) . Corre- BioTechniques Focus: Proteomics lation analysis of two independent human serum experiments, including 99% confidence interval and 99% prediction interval calculations, were performed in SigmaPlot. Standard deviations and all other calculations were performed in Microsoft Excel. Guinea pig BALF and serum library screening data were further analyzed to derive kinetic rates of cleavage by linear and nonlinear regression. For each well with end point fluorescence fold change >2, linear slope and nonlinear rate data were derived from regression analyses (GraphPad Prism). For nonlinear regression, a one-phase exponential association model was used with the following parameters: least-squares fit, k > 0, maximum 1000 iterations. Correlation analyses of the three quantification methods (end point fluorescence fold change, linear slope, and nonlinear rate) were performed, and Pearson product moment correlation coefficients were calculated (SigmaPlot).
For deconvolution of selected IQFP motifs, proteolytic cleavage of individual IQFPs was assayed as described in the library screening procedure with modifications. IQFPs were custom synthesized, confirmed by MS, and provided as lyophilized powders (Mimotopes). IQFP stock solutions were prepared at 10 mM in DMSO by addition of 200-300 µL DMSO to 2-3 µmol peptide and stored at -20°C. In control experiments, the presence of DMSO at the low levels used in these studies did not affect fluorescence (data not shown). Working dilutions of IQFPs were added to BALF or serum in wells of low volume black microplates, and time-resolved fluorescence data were recorded as described. Assay wells contained 100 µM IQFP in 20 µL HEPES buffer (buffer composition as described) and 20 µL BALF or serum. Fold change after 6 h was calculated as f final /f initial , and the two IQFPs demonstrating the greatest extent of cleavage from each selected library well were selected for additional characterization. Effects of photobleaching were addressed through the inclusion of controls containing uncleaved peptides throughout all experiments, as well as through kinetic measurements of the fluorescence of both cleaved and uncleaved control peptides. An IQFP containing the amino acid sequence Ala-Thr-Glu, which was not cleaved by either BALF or serum, was included as an additional negative control.
To determine the effect of class-specific protease inhibitors on the cleavage of selected IQFPs by BALF and serum proteases, cleavage assays were performed as described in the presence of the following inhibitors: 8 mM 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF; serine proteases), 20 mM EDTA (metalloproteases), 20 µM E-64 (cysteine proteases), and 20 µM pepstatin A (aspartic proteases). To determine the limit of detection of an individual protease in BALF or serum, recombinant human prolyl oligopeptidase (R&D Systems, Minneapolis, MN, USA) was selected for titration into BALF, because BALF was devoid of prolyl endopeptidase specificity in our library screen. In this experiment, 0.5 µg/mL prolyl oligopeptidase activity was detectable in BALF (Supplementary Figure S1) .
IQFP cleavage sites were determined by identification of C-terminal IQFP fragments by matrix-assisted laser desorption/ ionization time-of-flight MS (MALDI-TOF MS). At the conclusion of the protease assays described above, 10 µL/well were removed, desalted, and concentrated with solid phase extraction micropipet tips (ZipTip C18; Millipore, Billerica, MA, USA) according to the manufacturer's instructions. Samples were eluted directly (1 µL each) onto a MALDI target plate and air-dried. Matrix solution (α-cyano-4-hydroxycinnamic acid in 50:50:0.1 water:acetonitrile:trifluoroac etic acid; 1 μL) was subsequently spotted on top of each sample and allowed to dry. Spectra were then acquired with an ABI 4800 MALDI TOF/TOF hybrid mass spectrometer (Applied Biosystems, Carlsbad, CA, USA). Intact parent peptides were identified through an analogous procedure from control wells containing IQFPs in buffer lacking BALF or serum. Cleavage sites were assigned by comparing observed peaks with calculated expected masses corresponding to cleavage at each possible site.
Results and discussion
We sought to determine if protease substrate specificity profiling can be used to identify differences in the proteolytic fingerprints of two clinically important fluids, serum and BALF. We selected BALF and serum for comparison for several reasons. First, the stark contrast between the two fluids may allow the method to be established and verified with confidence. Second, both BALF and serum are clinically relevant for diagnosis and therapy of numerous diseases. The importance of serum is well known; BALF, obtained from lavage of the lungs with buffered saline, is an important sample for clinical laboratory evaluation of many respiratory diseases (18) . Third, our study establishes a protease specificity signature that can serve as a baseline for future analysis of diseased samples, much like MS-derived baseline proteomes are often referenced in later investigations of diseased proteomes (12) . Fourth, information regarding differential proteolytic specificities of BALF and serum may be used to design and optimize tissue-specific prodrugs, drug delivery systems, and imaging contrast agents (19) .
To assess the reproducibility of the IQFP library screening procedure, we first assayed pooled normal human serum in two independent experiments (Figure 1 , B-D). The protease specificity "fingerprint" can be visualized in a heatmap format, in which the brightness of each pseudocolored square represents the extent of cleavage of the probe substrates in the corresponding well, expressed as fluorescence fold change ( Figure  1B ). The similarity of the two independent human serum screens was qualitatively evident from comparison of the heatmaps. Linear regression analysis supported a 1:1 relationship of the two data sets (r 2 = 0.771) with only 12 points (2.3%) falling outside the 99% prediction intervals ( Figure 1C ). Seventy-two of 114 total positive wells (63.1%) were identified in both experiments, while 25 (21.9%) were found only in Experiment 1, and 17 (14.9%) were found only in Experiment 2. The heterogeneity of microtiter plates or library synthesis is an unlikely explanation for this modest variability, because the libraries are subjected to rigorous quality control (10) . A more likely explanation involves inherent biological variability arising from different donors contributing the two independent lots of pooled serum (20) . A complete list of sequences and motifs cleaved by human serum is reported in Supplementary Tables S1 and S2. We then comparatively assessed the proteolytic profiles of pooled BALF and serum from guinea pigs. When visualized in heatmap format, the protease specificity fingerprints of guinea pig BALF and serum were strikingly different (Figure 2) .
Having observed this stark contrast, we performed a rigorous analysis of the amino acid distribution and most abundant motifs cleaved in each sample (Figure 3) . BALF proteases preferentially cleaved substrates containing aliphatic and aromatic amino acids, most notably Phe/Tyr (29 hits or 29.9% of Xaa, 20 hits or 20.6% of Yaa, 14 hits or 14.4% of Zaa) and Ile/Leu (36 hits or 37.1% of Xaa, 26 hits or 26.8% of Yaa, 9 hits or 9.3% of Yaa) ( Figure 3A ). These substrates were organized into motifs (each comprised of five or more assay wells) with two fixed positions and one variable position. Of the 25 substrate motifs cleaved by BALF but not by serum, each contained Phe/Tyr or Ile/Leu at one or more fixed positions. The 10 motifs with the highest mean fold change are shown in Figure 3C . Cationic residues (Arg/Lys) were almost completely absent from the substrate sequences cleaved by BALF.
In contrast, serum proteases cleaved substrates containing aliphatic and aromatic residues to a much lesser extent, but cleaved substrates containing cationic residues (Arg/Lys) quite strongly (17 hits or 12.1% of Xaa, 45 hits or 31.9% of Yaa, 33 hits or 23.4% of Zaa) ( Figure 3B ). Most notably, however, proline was prevalent among substrates cleaved by serum, particularly in the Xaa position (53 hits or 37.6% of Xaa, 14 hits or 9.9% of Yaa, 19 hits or 13.5% of Zaa). The extent of cleavage of proline-containing substrates, as quantified by fluorescence fold change, was considerably greater than that of substrates that did not contain proline; of the 31 motifs cleaved by serum but not BALF, the top 15 all contained proline at the Xaa position. Complete lists of sequences and motifs cleaved by BALF and serum are reported in Supplementary Tables S3-S6. Linear and nonlinear regression analyses provided information regarding kinetic rates of cleavage that was not reflected in end point fluorescence fold change measurements (Supplementary Tables  S3-S6) . Overall, the cleavage rates correlated well with the end point fold change data, although nonlinear regression failed to converge for some wells that were cleaved to a lesser extent (end point fluorescence fold change ~2.0-2.5). For sequences cleaved by BALF, a strong positive correlation between linear slope and end point fluorescence was observed (r 2 = 0.674, P < 0.0001), whereas nonlinear rate and end point fluorescence were positively correlated with poor significance (r 2 = 0.086, P = 0.016), and linear slope and nonlinear rate failed to show a positive correlation (r 2 = 0.020, P = 0.259) (Supplementary Figure S2) . For sequences cleaved by serum, strong positive correlations were observed in all three comparisons (P < 0.001) (Supplementary Figure  S3) . Cleavage rates fell within a range of 0.05-0.30 h -1 for most BALF and serum proteases, with the exception of a population of sequences that were cleaved much more rapidly by serum proteases (Figure 3, E and  F) . Most of these rapidly cleaved sequences contained Pro at the Xaa position, providing further evidence of the predominance of Pro-cleaving proteases in serum.
To clarify the substrate specificities of BALF and serum proteases, we synthesized individual peptides corresponding to two representative wells cleaved by BALF and serum in the library screens. Each well was deconvoluted by determination of the cleavage activities of each of the individual constituent peptides (Figure 4) . BALF proteases exhibited unambiguous cleavage preferences for both selected motifs (Figure 4,  A and B) . Among Ile/Leu-Phe/Tyr-Phe/Tyr sequences, Leu-Phe-Tyr was optimal, and Tyr was strongly preferred at the Zaa position. Among Ser/Thr-Ile/Leu-Asn/Gln sequences, the optimal sequence was Ser-Leu-Gln, with Ser strongly preferred at the Xaa position. The optimal sequences from serum protease motifs Pro-Asn/Gln-Ala/Val and Pro-Asn/Gln-Pro were Pro-Asn-Ala and Pro-Gln-Pro, respectively ( Figure 4, C and D) . These two serum motifs did not exhibit clear preferences at the Yaa or Zaa positions. From each of the four motifs, the top two sequences were selected for further characterization.
Cleavage of individually synthesized peptides by BALF and serum was also confirmed by MALDI-TOF MS. In each case, the expected parent (uncleaved) peptide was identified in control experiments. We observed C-terminal cleavage fragments corresponding to at least one cleavage site for seven of the eight peptides monitored (Supplementary Table S9 ). Several sequences exhibited multiple cleavage sites, which is not surprising given that multiple active proteases are likely to be present in both BioTechniques Focus: Proteomics BALF and serum. When analyzing the cleavage of proline-containing motifs in serum, we identified fragments corresponding to cleavage of some substrates after proline, supporting the possibility that prolyl endopeptidases may be responsible for this activity. One unexpected result was the identification of fragments corresponding to cleavage of Pro-Asn-Pro and Pro-Gln-Pro at the Pro-Asn/Gln↓Pro position. Prolyl endopeptidases are known to cleave at the C-terminal side of proline residues; however, it is possible that aminopeptidases hydrolyze Asn and Gln from the N terminus following cleavage of the Pro↓Asn/Gln-Pro bond to generate the fragments we observed.
In BALF, the predominance of proteases cleaving aliphatic and aromatic residues at each of the three variable positions of the library (77.3% of Xaa, 56.7% of Yaa, 38.1% of Zaa) indicates the presence of a protease repertoire distinct from that of serum. Although BALF and serum differ in their overall composition (11, 12) , some degree of overlap exists resulting from passive or facilitated transport of blood proteins into the alveolar space (21) . The stark distinction of BALF and serum proteolytic profiles, particularly the absence of Pro and Arg/Lys cleavage specificities in BALF, may result from inhibition or degradation of serum-derived proteases in the lung environment. In addition, the reduced cleavage of substrates containing cationic residues in BALF may be due to the lower abundance of proteases associated with the clotting and complement cascades (11, 12) . Partial inhibition of BALF proteases in the presence of a serine protease inhibitor (AEBSF) and a metalloprotease inhibitor (EDTA) indicated a role for proteases of these two classes in cleavage (Supplementary Figure S4A ).
Many abundant serine proteases in serum, including the kallikreins, thrombin, and constituents of the complement cascade, exhibit a preference for substrates that contain cationic amino acids (12, 22, 23) . Indeed, we observed that cationic residues are prevalent in substrates cleaved by guinea pig serum ( Figure 3B) . Notably, the cleavage pattern of human serum closely matched that of guinea pig serum, although the overall cleavage activity of human serum was lower, perhaps due to differential processing of the commercially obtained human serum preparation (Supplementary Tables S1, S2 , S5, and S6). The similarity of the human and guinea pig serum protease specificity fingerprints supports the possibility that studies of nonhuman samples can provide useful information translatable to human proteases.
Cleavage of proline-containing substrates by serum was predominant, both in terms of the amino acid frequency and the extent of cleavage (Figures 2 and 3) . Several soluble prolyl endopeptidases, including prolyl oligopeptidase and antiplasmin-cleaving enzyme, are present in serum (24) . These enzymes regulate the action of numerous bioactive peptides, including substance P, thyotropinreleasing hormone, arginine-vasopressin, and angiotensin II (24) . Changes in serum prolyl endopeptidase activity have been reported in numerous neurological diseases (24) , and prolyl endopeptidases may participate in inflammatory pathways as well (25) . To our knowledge, the extent of prolyl endopeptidase activity in serum in comparison with other proteases has not been reported previously. Our data indicate that prolyl endopeptidases are prevalent in serum, supporting continued efforts to determine their physiological roles.
A large number of library wells (192) were not cleaved by either serum or BALF (Supplementary Tables S7 and S8 ). These sequences contained a disproportionate frequency of Asp/Glu and Asn/Gln residues; 79.2% of uncleaved sequences contained at least one of the two. This is not surprising, because Asp/Glu residues are relatively uncommon among protease substrates. Although it is possible that the sequences containing these particular residues are simply uncleavable in the synthetic IQFP format, this explanation is unlikely, because Asn/Gln-containing IQFP sequences were previously found to be cleaved by calpain-2 (10). Also frequent among the uncleaved library wells were sequences containing Pro in the Yaa position (25.0% percent of all uncleaved sequences), suggesting that serum and BALF proteases recognize Pro-containing sequences preferentially when Pro is adjacent to a Gly residue (Xaa or Zaa positions).
Despite the promise of this approach, a few important caveats should be noted. By design, the library is restricted to identification of endoproteases. Also, because exopeptidases may subsequently act on cleaved IQFPs, MALDI-TOF MS-derived information regarding cleavages sites may reflect the action of multiple proteases. In addition, activities of proteases (and inhibitors) in serum and other biological environments are dependent on buffer, concentration, and other conditions related to sample preparation (26) . Thus, ex vivo observations may not always accurately represent the in vivo situation. Similarly, synthetic octapeptide sequences may not recapitulate the folded structures of endogenous substrates. Nonetheless, ex vivo analysis is typically the first step in identification and characterization of proteases in serum and other biological fluids (4, 5) .
Substrate specificity profiling can complement existing proteomics techniques in assessment of differences in protease specificity between complex samples. Measurements of abundance alone may not be sufficient for identification of diagnostic or therapeutic targets, because the identified proteases may be inactive or proteolytically degraded. Moreover, protease inhibitors are abundant both in serum and in the lung (11, 12) , so proteases may be present but inactivated by their respective inhibitors. Although a small (192 sequences) solid-phase library was previously used to detect proteolytic specificity of clinical blood samples, BioTechniques Focus: Proteomics our approach expands probe sequence space by 17-fold and permits more physiological solution-phase kinetics as compared with that study (27) . MS-based exoprotease substrate profiling has recently been suggested for cancer biomarker discovery as well, further supporting this approach (28) . Once proteolytic specificities of interest are identified, the responsible proteases can be identified through the use of active sitedirected probes designed from the known substrate specificity, as demonstrated by Saghatelian and coworkers for selective isolation of metalloproteases (7) .
In summary, we developed a simple but robust method for mapping the proteolytic specificities of complex biological fluids. Substrates identified using this method may serve as sensors for diagnosis and imaging purposes (19) , scaffolds for focused synthesis of substrates and inhibitors (29) , probes in the design of robust assays for inhibitors (30) , and triggers for controlled drug delivery (31) .
